Floatz logo

ep0062

Hormone Receptor Positive HER-2 Negative Breast Cancer

Ellipses PharmaPhase 1/2Active
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
81/ 100

Competitive context

22 Active assets in the Hormone Receptor Positive HER-2 Negative Breast Cancer cohort.

Asset / SponsorPhaseRating
Letrozole
BeOne Medicines
Phase 4BB
FULVESTRANT
BeiGene
Phase 2/3B
Elacestrant
GBG Forschungs GmbH
Phase 2B
Cyclophosphamide
Puma Biotechnology, Inc.
Phase 3B
Carboplatin
Fudan University
Phase 3B

View all 24 →

Same molecule, other indications

ep0062 is also rated in:

hormone receptor-positive breast cancerDormant
CC
Indicative ·
47 / 100
View asset →
breast cancerDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →